Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|March 11, 2015
Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinomaAaron Sabolch, Tobias Else, Kent A Griffith, et al.
Molecular and Cellular Biology|May 16, 2003
Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient miceFelix Beuschlein, Brendan D Looyenga, Stephanie E Bleasdale, et al.
The Journal of Endocrinology|July 14, 2006
Gonadectomy in mice of the inbred strain CE/J induces proliferation of sub-capsular adrenal cells expressing gonadal marker genesInga K Johnsen, Marc Slawik, Igor Shapiro, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2016
Molecular Heterogeneity in Aldosterone-Producing AdenomasKazutaka Nanba, Andrew X Chen, Kei Omata, et al.
Plos One|December 7, 2011
Aged PROP1 deficient dwarf mice maintain ACTH productionIgor O Nasonkin, Robert D Ward, David L Bavers, et al.
World Journal of Surgery|April 25, 2012
Worsening central sarcopenia and increasing intra-abdominal fat correlate with decreased survival in patients with adrenocortical carcinomaBarbra S Miller, Kathleen M Ignatoski, Stephanie Daignault, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term resultsGary D Hammer, J Blake Tyrrell, Kathleen R Lamborn, et al.
Molecular Genetics and Metabolism|March 1, 2006
IMAGe association and congenital adrenal hypoplasia: no disease-causing mutations found in the ACD geneJanna E Hutz, Andrea S Krause, John C Achermann, et al.
Molecular and Cellular Endocrinology|February 10, 2024
Chronic activation of adrenal Gq signaling induces Cyp11b2 expression in the zona fasciculata and hyperaldosteronismDesmaré van Rooyen, Antonio M Lerario, Donald W Little, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2009
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinomaPaul Haluska, Frank Worden, David Olmos, et al.
Pageof 14